254 related articles for article (PubMed ID: 34711512)
21. Genitourinary syndrome of menopause.
Farrell Am E
Aust Fam Physician; 2017; 46(7):481-484. PubMed ID: 28697291
[TBL] [Abstract][Full Text] [Related]
22. Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens - Cluster analysis of a web-based Italian survey among women over 40.
Nappi RE; Di Carlo C; Cucinella L; Gambacciani M
Maturitas; 2020 Oct; 140():72-79. PubMed ID: 32616374
[TBL] [Abstract][Full Text] [Related]
23. Local hormone therapy for genitourinary syndrome of menopause in breast cancer patients: is it safe?
Oyarzún MFG; Castelo-Branco C
Gynecol Endocrinol; 2017 Jun; 33(6):418-420. PubMed ID: 28277141
[TBL] [Abstract][Full Text] [Related]
24. Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study.
Matarazzo MG; Sarpietro G; Fiorito D; Di Pasqua S; Ingrassano S; Panella MM; Cianci A; Caruso S
Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():67-71. PubMed ID: 34167036
[TBL] [Abstract][Full Text] [Related]
25. Current challenges in the pharmacological management of genitourinary syndrome of menopause.
Salvatore S; Benini V; Ruffolo AF; Degliuomini RS; Redaelli A; Casiraghi A; Candiani M
Expert Opin Pharmacother; 2023 Jan; 24(1):23-28. PubMed ID: 36444726
[TBL] [Abstract][Full Text] [Related]
26. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
[TBL] [Abstract][Full Text] [Related]
27. Deconstructing the genitourinary syndrome of menopause.
Vieira-Baptista P; Marchitelli C; Haefner HK; Donders G; Pérez-López F
Int Urogynecol J; 2017 May; 28(5):675-679. PubMed ID: 28293790
[TBL] [Abstract][Full Text] [Related]
28. Update on management of genitourinary syndrome of menopause: A practical guide.
Palacios S; Castelo-Branco C; Currie H; Mijatovic V; Nappi RE; Simon J; Rees M
Maturitas; 2015 Nov; 82(3):308-13. PubMed ID: 26261035
[TBL] [Abstract][Full Text] [Related]
29. Genitourinary syndrome of the menopause--dawn of a new era?
Panay N
Climacteric; 2015; 18 Suppl 1():13-7. PubMed ID: 26366795
[TBL] [Abstract][Full Text] [Related]
30. The prevalence and determinants of genitourinary syndrome of menopause in Chinese mid-life women: a single-center study.
Geng L; Zheng Y; Zhou Y; Li C; Tao M
Climacteric; 2018 Oct; 21(5):478-482. PubMed ID: 29734845
[TBL] [Abstract][Full Text] [Related]
31. Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis.
Comini ACM; Carvalho BM; Moreira MJB; Reis PCA; Colapietro L; Northern J; Batalini F
Clin Breast Cancer; 2023 Dec; 23(8):835-846. PubMed ID: 37806915
[TBL] [Abstract][Full Text] [Related]
32. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
[TBL] [Abstract][Full Text] [Related]
33. Prasterone: A Review in Vulvovaginal Atrophy.
Heo YA
Drugs Aging; 2019 Aug; 36(8):781-788. PubMed ID: 31290076
[TBL] [Abstract][Full Text] [Related]
34. The urogenital system and the menopause.
Calleja-Agius J; Brincat MP
Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796
[TBL] [Abstract][Full Text] [Related]
35. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
36. Genitourinary syndrome of menopause in breast cancer survivors:Treatments are available.
Moreno AC; Sikka SK; Thacker HL
Cleve Clin J Med; 2018 Oct; 85(10):760-766. PubMed ID: 30289755
[TBL] [Abstract][Full Text] [Related]
37. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577
[TBL] [Abstract][Full Text] [Related]
38. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
Menopause; 2014 Oct; 21(10):1063-8. PubMed ID: 25160739
[TBL] [Abstract][Full Text] [Related]
39. Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India.
Ulhe SC; Acharya N; Vats A; Singh A
Cureus; 2024 Feb; 16(2):e54802. PubMed ID: 38529421
[TBL] [Abstract][Full Text] [Related]
40. Menopause, skin and common dermatosis. Part 3: genital disorders.
Musbahi E; Kamp E; Ashraf M; DeGiovanni C
Clin Exp Dermatol; 2022 Dec; 47(12):2123-2129. PubMed ID: 36103137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
